Different regulation of c-Myc- and E2F-1-induced apoptosis during the ongoing cell cycle

Oncogene

Volumn 18, Issue 3, 1999, Pages 843-848

  Hengstschläger, Markus ^a   Hölzl, Gabriele ^a   Hengstschläger Ottnad, Elke ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; c Myc; Cell cycle; Centrifugal elutriation; E2F 1

Indexed keywords

DACTINOMYCIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL DIFFERENTIATION; ONCOGENE C MYC; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; PROTO-ONCOGENE PROTEINS C-MYC; RATS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 0033590621     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202342     Document Type: Article

References (30)

1. Askew DS, Ashmun RA, Simmons BC and Cleveland JL. (1991). Oncogene, 6, 1915-1922.
2. Bouchard C, Staller P and Eilers M. (1998). Trends Cell Biol., 8, 202-206.
3. Borner C. (1996). J. Biol. Chem., 271, 12695-12698.
4. Dao T, Huleatt JW, Hingorani R and Crispe IN. (1997). J. Immunol., 159, 4261-4267.
5. Eilers M, Picard D, Yamamoto KR and Bishop JM. (1989). Nature, 340, 66-68.
6. Evan GI, Brown L, Whyte M and Harrington E. (1995). Curr. Opin. Cell. Biol., 7, 825-834.
7. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. (1992). Cell, 69, 119-128.
8. Field SJ, Tsai F-Y, Kuo F, Zubiaga AM, Kaelin WG, Livingston DM, Orkin SH and Greenberg ME. (1996). Cell, 85, 549-561.
9. Galaktionov K, Chen X and Beach D. (1996). Nature, 382, 511-517.
10. Harrington EA, Bennett MR, Fanidi A and Evan GI. (1994). EMBO J., 13, 3286-3295.
11. Hateboer G, Kerkhoven RM, Shvarts A, Bernards R and Beijersbergen RL. (1996). Genes Dev., 10, 2960-2970.
12. Helin K. (1998). Curr. Opin. Gen. Dev., 8, 28-35.
13. Hengstschläger M, Pusch O, Soucek T, Hengstschläger-Ottnad E and Bernaschek G. (1997). BioTechniques, 23, 232-237.
14. Hofmann F, Martelli F, Livingston DM and Wang Z. (1996). Genes Dev., 10, 2949-2959.
15. Hsieh J-K, Fredersdorf S, Kouzarides T, Martin K and Lu X. (1997). Genes Dev., 11, 1840-1852.
16. Hueber A-O, Zörnig M, Lyon D, Suda T, Nagata S and Evan GI. (1997). Science, 278, 1305-1309.
17. Kowalik TF, DeGregori J, Schwarz JK and Nevins JR. (1995). J. Virol., 69, 2491-2500.
18. Littlewood TD, Hancock DC, Danielian PS, Parker MG and Evan GI. (1995). Nucl. Acids Res., 23, 1686-1690.
19. Packham G, Porter CW and Cleveland JL. (1996). Oncogene, 13, 461-469.
20. Phillips AC, Bates S, Ryan KM, Helin K and Vousden KH. (1997). Genes Dev., 11, 1853-1863.
21. Pusch O, Bernaschek G, Eilers M and Hengstschläger M. (1997). Oncogene, 15, 649-656.
22. Qin X-Q, Livingston DM, Kaelin WG and Adams PD. (1994). Proc. Natl. Acad. Sci. USA, 91, 10918-10922.
23. Reed JC. (1996). Behring Inst. Mitt., 97, 72-100.
24. Rudolph B, Zwicker J, Saffrich R, Henglein B, Müller R, Ansorge W and Eilers M. (1996). EMBO J., 15, 3065-3076.
25. Shan B and Lee W-H. (1994). Mol. Cell. Biol., 14, 8166-8173.
26. Soucek T, Pusch O, Hengstschläger-Ottnad E, Adams PD and Hengstschläger M. (1997). Oncogene, 14, 2251-2257.
27. Strasser A, O'Conner L, Huang DCS, O'Reilly LA, Stanley ML, Bath ML, Adams JM, Cory S and Harris AW. (1996). Behring Inst. Mitt., 97, 101-117.
28. Vairo G, Innes KM and Adams JM. (1996). Oncogene, 13, 1511-1519.
29. Wu X and Levine AJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 3602-3606.
30. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E and Dyson NJ. (1996). Cell, 85, 537-548.